NEW YORK (GenomeWeb News) – Thermo Fisher Scientific informed about 230 employees earlier this year that their jobs are being eliminated, the company disclosed in a document filed with the US Securities and Exchange Commission last week.

In its Form 10-Q, Thermo Fisher said that its severance costs totaled $10 million for the first quarter ended March 31 for the job cuts across all three of its segments — Analytical Technologies, Specialty Diagnostics, and Laboratory Products and Services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

The New York Times editorial board weighs in on scientific research misconduct.